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INTRODUCTION
Metazoan genomes are encoded with multiple overlapping layers of information required for the precise control of gene expression. The splicing code has co-evolved with the genetic code and regulates the post-transcriptional expression of protein coding genes (for review see Wang & Cooper 2007) . In the nucleus, splicing is required to remove intervening sequences (introns) from precursor messenger RNAs (pre-mRNAs) and to correctly join protein-encoding regions (exons) together. Inclusion of an exon into the mature mRNA is regulated by cis-acting RNA elements known as exonic or intronic splicing enhancers and silencers (ESE, ISE and ESS, ISS, respectively) that function to recruit trans-acting RNA binding proteins. In the cytoplasm, these same RNA elements are decoded by tRNAs and the ribosome in order to template protein synthesis. Alternative splicing allows a single gene to express many different protein isoforms by including all, some or none of a specific exon sequence in the mRNA (for review see Maniatis and Tasic 2002) . Current estimates suggest that at least 70% of protein coding genes undergo alternative splicing (Wang & Cooper 2007) . However, understanding how these events are regulated and coordinated represents a major challenge.
Classification of functional cis-acting RNA elements on a global scale is required to begin the arduous task of defining the specific outputs from every human gene (For review, see Wang and Burge 2008) . Combinations of elegant computational studies and biochemical assays are now beginning to address this important problem in gene regulation. A variety of bioinformatics strategies have identified hundreds of putative cis-acting sequences that are enriched with regulated exons or introns. These studies have included sequences that function as independent, non-redundant regulatory units and those that work together and have therefore co-evolved (Fairbrother et al. 2002; Zhang and Chasin 2004; Zhang et al. 2005; Wang et al. 2006; Xiao et al. 2007; Friedman et al. 2008) . One caveat is that the cognate RNA binding proteins often escape identification. By contrast, biochemical studies such as the selected Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genome.cshlp.org Downloaded from evolution of ligands by exponential enrichment (SELEX) can reveal the nucleotide sequences recognized by specific RNA binding proteins (Tuerk and Gold 1990; Tacke and Manley 1995; Liu et al. 1998; Cavaloc et al. 1999; Smith et al. 2006) . However, these sequences are often degenerate and lack sufficient specificity to reveal the global organization of protein-RNA interactions. One of the most powerful methodologies used to examine interactions of RNA binding proteins with their cognate targets is the RNA immunoprecipitation-microarray experiment (RIP-Chip). RIP-Chip is similar to chromatin IP-microarray analysis (ChIP-Chip) with the exception that it is RNA-protein rather than DNA-protein interactions that are assayed (Tenenbaum et al. 2002; Sanchez-Diaz and Penalva. 2006) . RIP-Chip is a robust method that has been applied to both yeast and metazoan systems and can reveal relationships between transcripts and regulatory RNA binding proteins. Interpretation of RIP-Chip experiments however requires caution owing to several technical considerations. In the absence of crosslinking reagents, RNA binding proteins are free to dissociate from their endogenous RNA targets and re-associate with higher affinity binding sites, thereby giving rise to a risk of false discovery (Mili and Steitz 2004) . Formaldehyde cross-linking of intact cells can preserve in situ protein-RNA interactions but can also induce protein-protein cross-links, thereby increasing the likelihood that RNA targets associated with other RNA binding proteins may be inadvertently copurified. Despite these issues, numerous studies employing RIP-Chip have suggested that RNA binding proteins exhibit distinct binding specificities (Brown et al. 2001; Hieronymus and Silver 2003; Gerber et al. 2004; Gama-Carvalho et al. 2006; Olson et al. 2007 ). These observations have led to the formulation of the hypothesis that the coordinated post-transcriptional control of functionally related transcripts is organized by specific RNA binding proteins (Keene 2007 ).
The RIP-related cross-linking immunoprecipitation (CLIP) method sidesteps several of the pitfalls described above (Ule et al. 2003; Ule et al. 2005a ). The primary advantages of this method over the other standard RNA IP methods include the following: (1) photo cross-linking of intact cells preserves the in situ RNA binding specificity, (2) partial RNase digestion liberates the Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genome.cshlp.org Downloaded from protein binding site from the full length transcript, (3) stringent purification conditions decrease contamination thereby enhancing the specificity of the assay, and (4) cloning and sequencing of purified RNA fragments directly identifies both the genomic locus from which the RNA transcript was derived, and the region recognized by individual RNA binding proteins. CLIP analysis has been successfully performed in a study of the murine RNA binding protein NOVA, a neural gene-specific alternative splicing factor involved in the human neurological disorder, paraneoplastic opsoclonus myoclonus ataxia (POMA; . CLIP analysis of NOVA identified a network of pre-mRNAs encoding proteins involved in post-synaptic functions that are regulated by NOVA at the level of alternative splicing. These data allowed the creation of a 'genomic map' capable of predicting alternative splicing events based upon the NOVA binding position .
Splicing Factor Arginine/Serine-Rich 1 (SFRS1, also known as SF2, ASF, ASF/SF2 and SF2/ASF) is a highly conserved, essential pre-mRNA splicing factor with dual functions in constitutive and alternative splicing (Ge et al. 1991; Krainer et al. 1991) . SFRS1 is a member of a large protein family known as the Serine and Arginine-rich proteins (SR proteins). SR proteins have a modular domain structure comprising one or two amino-terminal RNA Recognition Motifs (RRMs) and a carboxyl-terminal domain composed almost exclusively of alternating serine and arginine repeats. SR proteins function at early stages of spliceosome assembly and play an important role in specifying splice site selection (for review see Lin and Fu 2007) . In cultured cells, SFRS1 shuttles between the nucleus and the cytoplasm and also participates in postsplicing RNA processing reactions including mRNA export, stability, nonsense-mediated decay and translation Huang and Steitz 2001; Lemaire et al. 2002; Sanford et al. 2004; Zhang and Krainer 2004) . Although many of the biochemical roles of SR proteins in premRNA splicing can be carried out by other family members, SFRS1 is absolutely required during both murine and nematode embryogenesis and for the maintenance of genome stability in mammalian cell culture models (Wang et al. 1996; Longman et al. 2000; Li and Manley 2005; 6 Xu et al. 2005) . SFRS1 is a proto-oncogene, located at 17q21.3-q22, which is amplified in many types of human tumor (Karni et al. 2007 ). The comprehensive identification of SFRS1 mRNA targets promises to improve our understanding of the diverse biological roles of SFRS1.
Despite numerous in vitro and in vivo studies, the RNA binding specificity of SFRS1 is not fully understood. Here we combine CLIP with high-throughput sequencing (CLIP-Seq).
CLIP-Seq proffers a comprehensive and cost-effective system for the identification of biologically relevant cis-acting RNA elements recognized by specific RNA binding proteins in the context of their cellular environment. Our data provide an unprecedented evaluation of the RNA binding specificity of the essential splicing factor SFRS1. CLIP-Seq identified a purine-rich consensus motif, which is present in a majority of exonic, intronic, ncRNA and intergenic transcripts co-precipitated by SFRS1. Analysis of exonic RNA fragments bound by SFRS1 revealed an enrichment of binding sites between 21-40 nt from the 5' or 3' splice sites. This sequence and its positional specificity were then used to predict SFRS1 binding sites that have been disrupted by mutations causing human inherited disease. This analysis identified 181 mutations (in 82 different genes) associated with genetic disease that abolished putative binding sites for SFRS1. These results suggest that defective protein-RNA interactions may play a rather broader role in human inherited disease than has previously been anticipated.
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RESULTS

Cross-linking Immunoprecipitation of SFRS1
We used CLIP to identify cis-acting RNA elements recognized by splicing factor SFRS1.
Three independent cultures of human embryonic kidney cells (HEK293T) exposed to UV and one control culture without UV-irradiation were used to prepare whole cell extracts as previously described (Sanford et al. 2005) . Following DNase and RNase treatment of the extracts, SFRS1 was precipitated using mAb 96 (Hanamura et al. 1998 ). Immunoprecipitation of SFRS1 was confirmed by western blot analysis. Precipitation of SFRS1 is dependent upon antibody and independent of UV irradiation ( Fig 1A; compare lanes 2, 3, 5, 6, 7 with lane 4). Radiolabeled SFRS1-RNA complexes were visualized by autoradiography in parallel with the western blot analysis. Precipitation of the 32 P-labeled complexes by the SFRS1 antibody was dependent upon UV cross-linking ( Fig 1B, compare lanes 1,2 with 4-6). Surprisingly, SFRS1 can be radiolabeled in the absence of UV irradiation. However, incorporation of 32 P is not dependent upon T4PNK, indicating that this signal is unrelated to SFRS1-RNA complexes (Fig. 1B, lanes 1,2). The bracket in Figure 1B designates the region purified from nitrocellulose membranes and corresponding to a 10-15 kDa increase in the apparent molecular weight of free SFRS1 (Fig.   1B , compare bracket to arrowhead marking the expected migration of SFRS1). RNA extracted from the nitrocellulose membrane was then amplified by reverse transcription polymerase chain reaction (RT-PCR). For comparison, non-selected input RNA was purified and amplified from RNase-treated HEK293T whole cell extracts. We directly sequenced CLIP-derived and input amplicons using the 454 Genome Sequencer FLX system (Margulies et al. 2005) . As expected from the mobility of the SFRS1-RNA complexes, the majority of purified RNA fragments were between 45-65 nt in length (Fig. 1C) .
High-Throughput Sequencing
Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genome.cshlp.org Downloaded from SFRS1-bound RNAs were analyzed in four independent CLIP-Seq experiments. In total, 932,152 reads were obtained from SFRS1-bound RNA. In addition, 670,448 reads from nonselected input RNA were generated from three independent experiments for comparison (Table   1 ). 99.8% and 91.6% of sequences derived from CLIP and input amplicon libraries contained information from both 5' and 3' RNA linkers, indicating that the vast majority of RNA fragments were sequenced completely. The sequences corresponding to RNA fragments were then filtered, based upon a minimum allowable size of 30 bp and no ambiguous base calls. After this filtering step, all redundant amplicon sequences were removed leaving a pool of 135,318 and 218,108 CLIP-or input-derived RNA fragments, respectively. The unique RNA fragments were aligned to the human genome using the Blast-like Alignment Tool (BLAT; Kent 2002) . RNA fragments derived from CLIP or input RNA samples mapped to 58,953 and 3,374 loci respectively, indicating that the CLIP sequences were far more diverse than those derived from the input samples. Overlapping clusters of unique amplicons were used to define the contiguous sequence blocks (henceforth referred to as "blocks"). Blocks derived from non-selected total RNA served as a reference sample. We assume that these unselected blocks correspond to the most abundant transcripts and may be a potential source of contamination in the CLIP-Seq dataset. Therefore, blocks common to both the input and CLIP-Seq were excluded from further analysis, despite the possibility that some very abundant RNAs might actually bind to SFRS1.
By applying this stringent filter, the abundant class may have been lost. However, this conservative approach ensured that only extensively enriched sequences would have been captured. Only 5% of the CLIP-derived blocks were present in the reference set.
SFRS1 consensus motif
Identification of the consensus site for SFRS1 is important in order to understand mechanisms of splice site selection. We used the motif finding algorithm Multiple EM for Motif Elicitation (MEME; Bailey and Elkan 1995) to identify RNA-binding sequences shared by sequenced fragments that cross-link to SFRS1 in vivo. There were 681 unique sequence blocks Cold Spring Harbor Laboratory Press on November 6, 2017 -Published by genome.cshlp.org Downloaded from present in at least three of the four CLIP-Seq experiments and absent from the input sequences. We randomly split this set in half, using 340 to train the MEME algorithm, and holding the remaining 341 blocks in reserve as part of a gold standard dataset. After picking a single representative amplicon at random from each sequence block, MEME identified a purinerich octamer containing a GAAGAA core ( Fig. 2A) . This motif is similar to several SFRS1 recognition sites previously identified by binding SELEX experiments and by mutational analysis of splicing enhancers in the fibronectin extra-domain A and cardiac troponin T alternative cassette exons (Caputi et al. 1994; Ramchatesingh et al. 1995; Tacke and Manley 1995) .
Computational methods searching for ESEs have also identified and validated the GAAGAA sequence as a functional splicing enhancer (Fairbrother et al, 2002) . We then calculated a positional weight matrix (PWM) from the SFRS1 consensus motif. The predictive power of the PWM was evaluated using two different statistical plots: the Accuracy curve, which calculates the accuracy of the binding site prediction as a function of matching score cutoff thresholds and the Receiver Operating Characteristic curves (ROC), which evaluate sensitivity and specificity of the binding site model (Fig. 2B,C) . For each plot, we used the PWM to scan a gold standard dataset, consisting of amplicons from the remaining 341 blocks as a positive component and an equal number of sequences picked at random from intergenic deserts as a negative component.
These measurements established the maximum accuracy, sensitivity and specificity of PWM as 78%, 81% and 77%, respectively. We therefore consider that the consensus binding site model presented in Figure 2 has a high probability of correctly identifying SFRS1 binding sites in silico.
Classification of SFRS1 binding sites
The UCSC Known Gene and Rfam databases were used to annotate each sequence block. Figure 3A depicts the strategy used for annotation. A total of 23,699 blocks were identified in the SFRS1 CLIP-Seq experiment (Fig. 3B) . The majority (73%) of these blocks mapped to loci annotated as protein coding genes. Of the 17,365 blocks present within protein coding genes, 83% were associated with exonic sequences. We sub-classified these exon-associated blocks into those that were contained exclusively within a single exon (10,532 blocks; 60%), those that spanned an exon-exon junction (2,245; 13%), those that spanned an exon-intron boundary (1,065; 6%) and those contained within an intronless gene (681; 4%). The remaining 17% (2,911) of blocks mapping to protein coding genes were present within introns.
Three files containing all of the genomic coordinates of blocks targeted by SFRS1, blocks present in the input sample and the positions of SFRS1 consensus sites can be found in the Supplementary Materials online.
SFRS1 binding sites associated with alternative splicing SFRS1 is a well-characterized splicing factor with roles in the regulation of alternative splicing (for review see Lin and Fu 2007) . We extracted a non-redundant version of the AltEvents database from the UCSC Genome Browser and used it to classify SFRS1 target exons based upon their relationship to constitutive or alternative splicing (Table 2 ). Some 88.8% (12,304) of the exonic binding sites of SFRS1 were localized to constitutive exons whereas only 11.2% (1,538) had evidence of alternative splicing in this database. Alternative cassette exons were the single most abundant classification followed by exons containing alternative 3' or 5' splice sites. Retained introns were the least common. The observed levels of these exons within the SFRS1 CLIP-Seq dataset differed significantly from the expected levels of each classification based upon their ratios to all exons annotated by the UCSC Known Gene database (Table 2 ). Both cassette exons and retained introns were under-represented in the pool of SFRS1 targets (Fisher's Exact test P < 1.6x10 -5 and 6.5x10 -4 , respectively). By contrast, exons with alternative 5' and 3' splice sites were enriched in the CLIP-Seq data relative to the genome (Fisher's Exact test P < 9.5x10 -14 and 6.4x10 -9 , respectively). Recent work from
Biamonti and co-workers (Ghigna et al. 2005) suggests that binding sites for SFRS1 in constitutive exons may regulate the inclusion or exclusion of adjacent cassette exons. We found that SFRS1 bound in equal proportions to exons immediately upstream or downstream of cassette exons (5' or 3' adjacent exons, respectively). We observed a significant enrichment in the CLIP-Seq dataset relative to the human genome for binding sites located within 5' and 3' adjacent exons (Fisher's Exact test P < 1.3x10 -10 and 5.4x10 -11 , for upstream and downstream exons, respectively).
Intronless Genes
Not all intragenic blocks fell within intron-containing genes; 681 binding sites in 332 PhastCons scores, were downloaded from the UCSC Genome Browser and reflect the overall conservation among seventeen vertebrate species (Felsenstein and Churchill 1996; Siepel et al. 2005 ). We determined the mean conservation score for each nucleotide within 1,200 bp of the center of each intergenic SFRS1 binding site. These data were then compared to intergenic regions randomly selected from the human genome ( Supplementary Fig. 2 ). The majority of SFRS1-bound RNA transcripts derived from intergenic regions were found to be highly conserved across multiple vertebrate lineages, suggesting a high degree of negative selective pressure at these sites.
SFRS1 binds to a subset of functionally related mRNAs
Keene (2007) Figure 4A . Based upon biological process annotations, involving several redundant layers, it is clear that the most enriched SFRS1 RNA targets encode proteins involved in gene expression in general and RNA processing specifically. In order to avoid potential bias due to highly abundant transcripts, we also defined the GO of the non-selected, RNase-digested input RNA. The enrichment of each annotation term in both the CLIP-Seq and non-selected input RNA relative to the human genome was calculated and ranked using EASE Scores. Relative to both the genome and non-selected input RNA, SFRS1 target mRNAs were found to be highly enriched for genes involved in biological processes related to pre-mRNA splicing, RNA processing and ribosome biogenesis (Fig. 4B ). By contrast, mRNAs encoding proteins functioning in processes such as chromatin and nucleosome assembly did not differ significantly between SFRS1 RNA targets and non-selected RNase-treated Input RNA samples, despite being enriched relative to the genome as a whole. As expected, the non-selected RNase-treated Input RNA samples contained a much wider array of GO-terms than the CLIPSeq targets (not shown).
Validation of SFRS1-RNA interactions
CLIP-Seq analysis of SFRS1 identified thousands of potential RNA targets. As with any high throughput method, it is necessary to gauge the accuracy of the CLIP-Seq targets using a secondary assay. In order to validate the SFRS1-RNA interactions, we used the RNAimmunoprecipitation (RIP) assay to determine if 78 RNA transcripts selected at random from the CLIP-Seq dataset interact with SFRS1 under native conditions. SFRS1 was found to be efficiently and specifically immunoprecipitated from whole cell extracts prepared from HEK293T cells (Fig. 5A , compare lanes 3 and 4). The increased mobility of SFRS1 observed in lane 4 is due to partial dephosphorylation of SFRS1 and can be blocked by inclusion of phosphatase inhibitors during the IP incubation (data not shown). Co-precipitated RNA was then isolated from input, control IP and anti-SFRS1 IP samples and analyzed by RT-PCR ( Fig. 5B and Supplementary Fig. 3 ). Of the 78 randomly selected target transcripts, 58 were detectable in both the input and anti-SFRS1 IP samples but not in RNA isolated from the control IP. These validated targets include many intergenic transcripts, demonstrating that these unannotated RNA transcripts are associated with SFRS1 in vivo. Nine interactions were classified as false positive on the basis that the transcript was either detected in both the control and SFRS1 IP (see Supplementary Fig. 3, ZNF66 ) or present only in the input sample but absent from the IP. It is possible that some non-validated interactions between SFRS1 and target RNAs were undetectable under non-cross-linking conditions. Eleven RNA targets were classified as technical failures since no detectable signal was observed in any RNA sample. In total, approximately 73% of randomly selected SFRS1 target transcripts could be validated by the RIP assays (Fig. 5C ). These data were in good agreement with the statistical evaluation of the SFRS1 consensus motif which correctly recognized ~78% of target RNA fragments.
The SFRS1 consensus motif is enriched near the boundaries of exons identified by CLIP-
Seq
Our data suggest that the robust consensus motif presented in Figure 2 The spatial relationship between binding site positions and splice sites can provide important mechanistic insights into molecular functions of RNA-binding proteins . Biochemical studies suggest that SR proteins function at early stages of spliceosome assembly and promote recognition of splice sites (Fu 1993; Kohtz et al. 1994; Graveley et al. 2001; Shen and Green 2004) . Indeed, the proximity of SR protein binding sites to splice sites is positively correlated with the in vitro splicing efficiency of reporter pre-mRNAs (Graveley and sequence that was derived from an exon or exon-intron boundary, we measured the distance in base-pairs (bp) from the midpoint of the amplicon sequence to the nearest 5' or 3' splice site. As with previous calculations, we determined the frequency of amplicon midpoints in 10 bp bins extending away from the splice sites. Each amplicon midpoint was counted only once with respect to either a 5' or 3' splice site, thereby ensuring that the genomic coordinates of each midpoint measurement contributed only to the nearest splice site. The amplicon midpoint frequencies were directly compared to an equal number of randomly selected points from exon sequences extracted from the human genome and from amplicon sequences derived from input RNA samples. The average frequencies for each bin were calculated over 40 replicate samplings. Figure 7D demonstrates that the midpoints of CLIP-Seq amplicons were restricted to specific positions relative to 5' and 3' splice sites (Fig. 7D , blue lines). Amplicons picked from the input samples also showed a slight positional bias relative to 5' and 3' splice sites (Fig. 7D , orange lines). However, CLIP-Seq amplicon midpoints were clearly enriched relative to the input samples. By contrast, randomly selected control "midpoints" displayed no positional bias (Fig.   7D , red lines). This analysis is independent of the positional weight matrix and therefore directly confirms that SFRS1 binding sites are enriched at specific distances (approximately 20-41 nt)
relative to splice sites. Given that the median lengths of internal constitutive and cassette exons identified by CLIP-Seq were found to be 142 nt and 158 nt, respectively, which are somewhat longer than their counterparts in the UCSC Known Gene database (125 nt and 108 nt, respectively), the data presented above reflect a clear positional bias of SFRS1 binding sites.
Many human disease mutations disrupt SFRS1 consensus sites
Single nucleotide substitutions or point mutations often alter the genetic code by producing aberrant protein products. However, although nonsense mutations introduce premature termination codons into the open reading frames of disease genes, it is often much more difficult to rationalize the pathogenic basis of missense and synonymous mutations. One explanation is that point mutations can manifest their detrimental effects through RNA processing. It is now well established that defects in pre-mRNA splicing and the regulation of alternative splicing can induce heritable disease in humans (for review see Wang and Cooper, 2007 (Teraoka et al. 1999; Liu et al. 2001; Cartegni and Krainer 2002; Moseley et al. 2002; Kashima and Manley 2003; Pagani et al. 2003) . Based upon these results and others, a considerable effort to identify splicing-relevant mutations using PWM generated by both binding and functional SELEX is now underway (Smith et al. 2006) . However, as stated above, different approaches for identifying the binding specificity of SFRS1 yield results that do not always concur. These differences serve to confound our understanding of the pathology of human inherited disease.
To investigate the potential impact of human disease-causing mutations on RNA processing (0.21%) that were predicted to give rise to the loss of an SFRS1 binding site. We therefore found that substitutions resulting in the loss of SFRS1 binding sites were enriched approximately four-fold in the HGMD mutation dataset relative to the control dataset (Fig. 8A, Fisher's Exact test, P-value < 10 -5 ). These data are consistent with previous studies showing that purifying selection reduces single nucleotide substitutions in exonic positions harboring splicing regulatory sequences (Majewski and Ott, 2002; Fairbrother et al. 2004; Parmley et al. 2006) .
We next posed the question of where the mutations causing the loss of SFRS1 binding sites were located relative to splice sites (Fig. 8B) . A significant advantage of CLIP-Seq is the large amount of raw data generated by the high throughput sequencing of amplicons. These data facilitate the elucidation of consensus sites using motif-finding algorithms such as MEME. The motif presented in Figure 2 was the only statistically significant sequence identified by MEME. The robust nature of the binding site model allowed for high resolution mapping of SFRS1 binding sites within the amplicon data.
This is important because future in silico analyses should focus on these positionally restricted windows for identification of SFRS1-regulated exons. Such an approach is exemplified by the search for SFRS1 binding sites abolished by inherited mutations causing human genetic disease. We identified 181 exonic mutations in 82 different disease genes that abolish putative SFRS1 binding sites. Nearly 87% of these mutations were located within 50 bp of the nearest splice site, a region already demonstrated by CLIP-Seq to be enriched in SFRS1 binding sites.
It is quite possible that mutations falling outside the preferred zone of SFRS1 binding will have little impact on RNA processing. However, at least five of the mutations identified here have already been correlated with changes in alternative splicing. Given that none of the mutations we identified were apparent in previously published reports identifying large numbers of splicingrelevant disease mutations, the pathological impact of exonic mutations upon splicing could turn out to be quite significant. Our findings argue that defective RNA processing, typically considered unusual in cases of non-synonymous disease mutations, could actually be the rule rather than the exception.
The CLIP method, developed in the Darnell laboratory at Rockefeller University, was first used to identify RNA targets of the splicing regulator NOVA. NOVA and SFRS1 are very different types of splicing factors and these differences are clearly reflected in their in situ RNA binding specificities elucidated by CLIP. NOVA and SFRS1 engage RNA through structurally distinct RNA binding domains. The K-homolog RNA binding domain of NOVA recognizes a pyrimidine-rich YCAY motif that is nearly three-fold more abundant in RNA fragments bound by NOVA relative to non-targeted sequences. By contrast, our study shows that SFRS1 binds a purine-rich octamer with a GAA GAA core. This motif is highly enriched in exons bound by SFRS1 relative to randomly selected exon sequences (Fig. 6) . The binding sites for both proteins within pre-mRNA are restricted to specific positions. Intronic and 3'UTR binding sites are most prevalent in the NOVA targets whereas internal exonic binding sites are strongly preferred by SFRS1 (Fig. 7) . Another interesting finding from our study is that binding sites for SFRS1 are enriched in exons that are adjacent to alternative cassette exons (Table 2) . A previous study demonstrated that SFRS1 binding sites in a constitutive exon regulated the skipping of an upstream alternative cassette exon in the receptor tyrosine kinase RON gene (Ghigna et al. 2005) . We propose that SFRS1 may play a prominent role in regulating this mode of competitive exon skipping by activating downstream splice sites. Finally, there are also significant differences between the functions of proteins encoded by mRNAs targeted by NOVA and SFRS1. NOVA mRNA targets tend to encode proteins involved in pre-and post-synaptic function as well as neuronal inhibition (Ule et al. 2003; Ule et al. 2005b) . By contrast, mRNAs encoding other RNA binding proteins are over-represented in the collection of SFRS1 targets. These include a statistically significant enrichment of other splicing factors (Fig. 4) . We are confident that the enrichment of RNA binding protein messages is biologically significant for several reasons. First, comparisons of SFRS1 targets with mRNAs present in the non-selected input RNA samples demonstrate that transcript abundance alone does not account for the enrichment of RBP mRNAs in the CLIPSeq dataset. Secondly, recent experiments describe auto-and trans-regulatory posttranscriptional networks involved in homeostatic control of RNA binding protein expression (Lareau et al. 2007; Ni et al. 2007; Barberan-Soler and Zahler 2008; Saltzman et al. 2008) . Two hallmarks of this mechanism include alternative splicing-coupled nonsense-mediated decay (AS-NMD) and ultraconserved cis-acting regulatory elements within coding exons of RBP mRNAs (Bejerano et al. 2004) . In many cases, the ultraconserved regions of RBP genes overlap alternative exons with the potential to induce NMD (Bejerano et al. 2004; Lareau et al. 2007; Ni et al. 2007 ). In total, we identified 8 out of 111 known ultraconserved regions within exonic sequences. Included in these ultraconserved binding sites are several other genes encoding RNA binding proteins such as SFRS1 itself, SFRS6, HNRPM, PBCP2 and CLK4 encoding SR protein kinase ( Supplementary Fig. 4) . We suggest that SFRS1 may be involved in controlling RBP homeostasis.
METHODS
Cell culture
Human embryonic kidney (HEK293T) cells were cultured in DMEM (Sigma), supplemented with 10% fetal calf serum and incubated at 37ºC in the presence of 5% CO 2 . For each CLIP experiment, cells were grown to 75% confluence in 15 cm plates.
Cross-Linking Immunoprecipitation (CLIP)
CLIP analysis of SFRS1 was performed as described (Ule et al. 2003) with the following modifications relating to extract preparation and RNase treatment. Whole cell lysates were prepared from UV-treated or control cells as previously described (Sanford et al. 2005 ). The soluble extract was treated with 30U RQ DNase 1 for 20 min at 37ºC. The reactions were terminated by the addition of 20 mM EDTA. Subsequently, ribosomal subunits were cleared by centrifugation of the extract at 100,000 x g using an Optima Max ultracentrifuge (Beckman Coulter, USA) in a TLA120.2 rotor for 20 min. Cleared extracts were then treated with a dilute cocktail of RNase A/T1 (Ambion, USA) at a final dilution of 1:10,000 for 20 min at 37ºC. 200 U RNaseOut (Invitrogen, USA) was then added to the extract. Proteins were then partially denatured by addition of an equal volume of buffer A (2X PBS, 0.2% SDS, 1% NP-40). An aliquot of each UV-treated extract was used to prepare input RNA fragments. The remainder of the extract was used for immunoprecipitation with anti-SFRS1 monoclonal antibody. Extracts were treated with proteinase K (Ambion, USA) at a final concentration of 2 mg/mL, phenol extracted twice and ethanol precipitated. The trimmed input RNA was then ligated to the 3' RNA linker, followed by the 5' RNA linker, and used as templates for RT-PCR as previously described (Ule et al. 2005a ). Gel-purified amplicons from the primary RT-PCR were re-amplified for 15 cycles using HPLC-purified primers that were complementary to the RNA linkers but also contained the 454 capture sequences (Margulies et al. 2005) as described in the original CLIP protocol (Ule et al. 2005a ). Amplicons were gel purified from 2% NuSieve Agarose gels using the QIAX II Gel Extraction kit (Qiagen).
High-throughput sequencing of amplicons
Prior to sequencing, the quality and quantity of gel-purified amplicons was assessed using a DNA LabChip1000 on an Agilent 2100 BioAnalyzer. High-throughput sequencing was performed using the Genome Sequencer FLX system (Roche Diagnostics) following standard protocols (Margulies et al. 2005) . Titration runs were performed for all samples.
Primers
All DNA oligonucleotides (sequences available on request) were synthesized by IDT Inc.
(Coralville, IA, USA).
capture primers:
P5454A (HPLC-purified): 5' GCC TCC CTC GCG CCA TCA GAG GGA GGA CGA TGC GG 3' P3454B (HPLC-purified): 5' GCC TTG CCA GCC CGC TCA GCC GCT GGA AGT GAC TGA CAC 3'
Mapping of high-throughput sequencing data to the human genome
Several QC steps were implemented prior to mapping amplicon sequences to the human genome. We removed any amplicon sequences that did not include a recognizable match to 5' and 3' RNA linkers used for amplifying the RNA library. Once amplicons with both linker sequences had been identified, sequences <30 bp were removed, as were sequences containing ambiguous base calls. Finally, to avoid complications from preferential amplification during PCR, redundant identical amplicon sequences were filtered out from each experiment and only representative amplicons were retained. In order to study the binding of SFRS1 on a genome-wide scale, the filtered amplicons were aligned using BLAT (Kent 2002 ) against human genome assembly hg18, March 2006 (NCBI build 36, accessed Oct. 18, 2007 (Karolchik et al. 2008 ). BLAT sequences containing more than 80% repetitive sequence were removed, and only 1 mismatch or 1 gap was allowed so that SNPs and splicing junctions could be accommodated.
The annotation strategy focused upon loci containing overlapping unique amplicons. We refer to these regions as sequence blocks (blocks). Blocks from each CLIP-Seq experiment were annotated using the UCSC Known Gene database (http://genome.ucsc.edu/ ; accessed on Oct.
18, 2007) (Karolchik et al. 2008 ) and the Rfam database. The annotation data was then subclassified in order to determine the number of blocks targeting specific genomic structures (exon, intron, exon-intron boundary, intergenic etc) and to determine the number of unique genomic structures identified in each experiment. To identify alternatively spliced exons bound by SFRS1, all binding sites were mapped against the Alternative Event Database (derived from AltEvent track in the UCSC Genome Browser (Karolchik et al. 2008) ). The binding sites that were not located in alternatively spliced exons were by default designated as constitutive exons (the set of unique exons in the UCSC Known Gene database excluding alternative spliced exons related to AltEvent track).
Modeling and statistical evaluation of the SFRS1 consensus-binding motif
In order to establish precisely where SFRS1 binds, the Multiple Em for Motif Elicitation (MEME) algorithm (version 3.5.7; http://meme.sdsc.edu/meme/intro.html) (Bailey et al. 2006 ) was used to determine the consensus motif of amplicons in CLIP-hit blocks that did not overlap input blocks. We focused on the 681 blocks detected by 3 out of 4 CLIP samples. A single amplicon sequence was randomly selected from each block. 300 of the randomly selected sequences were used to perform MEME analysis and 300 sequences were used as the positive component of 'gold standard' sequences to evaluate the predictive power of the derived consensus motif.
This procedure was repeated 20 times. The ROC curve was selected which had the maximum area under the curve (AUC) and its corresponding PWM (Positional Weight Matrix) was taken as the final prediction of the SFRS1 consensus motif (Fig. 2) . The PWM can be found in Supplementary Table 1 in the supporting on-line materials. During each ROC analysis, 40 groups of background sequences were selected to compare with the gold standard sequences.
The background sequences were identical in length to the gold standard data set but were selected at random from intergenic desert regions (defined for practical purposes as having no genes within 100,000 bp upstream or downstream) from the chromosomes contributing to each gold standard sequence; any blocks from the CLIP experiments were deleted. After scanning each gold standard (true positive) and background sequence (false positive) using PWM derived from MEME, we computed the binding scores for each octamer, based upon which TP (True Positive), TN (True Negative), FP (False Positive) and FN (False Negative) rates were calculated at different score cut-off thresholds. Averaging 40 groups of these data, we plotted a final averaged ROC curve, precision-recall curve and accuracy curve using the ROCR package (Sing et al. 2005 ). As mentioned above, we selected the ROC curve that gave the maximum AUC as our final result; its predictive power is illustrated in Fig. 2b . We adopted the cut-off value 5.2, corresponding to the maximum accuracy of prediction, as the threshold to ascertain whether or not a given octamer was likely to be a bona fide binding site. To evaluate the relationship of the SFRS1 PWM to the majority of CLIP-Seq data, the average number of binding sites per nucleotide was calculated for blocks from alternative cassette or constitutive exons identified by CLIP-Seq or an equal number of blocks selected at random from protein coding genes. Wilcoxon's Signed-Rank test was used to evaluate the statistical significance of the data.
Gene ontology analysis
We identified all genes targeted by 3 out of 4 CLIP samples, and then excluded those genes which were targeted by any INPUT sample. The gene list containing these genes was then input into EASE (Hosack et al. 2003 ) (Expression Analysis Systematic Explorer, version 2.0; http://david.abcc.ncifcrf.gov/ease) to compute the overrepresented functional categories in "Biological Process", "Cellular Component" and "Molecular Function" systems (Hosack et al. 2003) . EASE scores (modified Fisher's Exact test probabilities by penalizing the count of positive agreement by 1) were computed for all categories in each system. Holm's correction method was applied to the data in order to identify the most significantly overrepresented gene categories, because the genes contained in each GO category were not mutually exclusive. We also performed a comparison between the ratios of genes hit by CLIP and the background gene lists (CLIP-hit ratio and Expected ratio). These data provided evidence for annotation enrichment relative to the entire genome. Because transcript abundance may also influence the protein-RNA interactions identified by CLIP-Seq, we also used analyzed mRNAs identified in the non-selected input RNA samples. Comparison of the annotation enrichment between the CLIPSeq and Input RNA samples was important as a means to identify specific targets that could have originated from highly transcribed genes.
SFRS1 binding site frequency relative to splice sites
Blocks identified by CLIP-Seq or randomly selected exon sequences from the human genome were scanned using the SFRS1 consensus PWM to identify statistically significant binding sites (those with binding scores above the matching score threshold of 5.2). As an additional control, we generated a PWM corresponding to the reverse complementary sequence of the SFRS1 binding site (see Supplementary Table 1 (Stenson et al. 2003) . However, we only examined those 21,700 single nucleotide substitutions from 440 genes (53.7% of all substitutions) that were located within internal coding exons. The 1436 SNPs derived from the SeattleSNPs resequencing project (http://pga.mbt.washington.edu/), selected for their high allele frequency, were assumed to be functionally neutral.
Mapping mutations predicted to disrupt SFRS1 binding sites
For each nucleotide substitution, a dataset comprising the wild-type and corresponding mutant exons was compiled. Using these data and a sliding window of 8 bp to evaluate the SFRS1 position weight matrix (PWM) using a threshold of 5.2, SFRS1 target sites were determined within the wild-type and mutant exons. Mutations reducing the matching score to levels below the score cut-off threshold of 5.2 were classified as loss of binding and vice versa for gain of binding. The net loss or gain for the set of 8-mers was then used to determine whether the result was an overall loss or gain of SFRS1 at any given position. The frequency and positional distribution of mutations predicted to give rise to a loss of SFRS1 binding sites was determined as described above.
Validation of SFRS1-RNA interactions
Anti-SFRS1 monoclonal antibody (60 uL cell culture supernatant/IP) was bound to 60 µL Quantification of block annotations. The majority of blocks were classified as "in gene" and were predominantly associated with exon sequences. Slightly more than 25% of blocks were defined as intergenic, but binding sites for SFRS1 within these transcripts were found to be highly conserved over evolutionary time (See Supplementary Fig. 2 ). 
